ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,600,000 | -8.4% | 3,000,000 | 0.0% | 0.19% | +16.4% |
| Q1 2022 | $3,930,000 | -25.6% | 3,000,000 | 0.0% | 0.16% | +15.4% |
| Q4 2021 | $5,280,000 | -18.9% | 3,000,000 | 0.0% | 0.14% | -2.1% |
| Q3 2021 | $6,510,000 | -38.0% | 3,000,000 | 0.0% | 0.15% | -31.5% |
| Q2 2021 | $10,500,000 | -55.6% | 3,000,000 | +25.0% | 0.21% | -49.0% |
| Q1 2021 | $23,664,000 | -12.7% | 2,400,000 | -4.0% | 0.42% | -28.2% |
| Q4 2020 | $27,100,000 | +46.2% | 2,500,000 | +38.9% | 0.58% | +29.3% |
| Q3 2020 | $18,540,000 | -1.3% | 1,800,000 | +100.0% | 0.45% | -14.4% |
| Q2 2020 | $18,792,000 | +220.6% | 900,000 | +50.0% | 0.53% | +112.1% |
| Q1 2020 | $5,862,000 | +142.2% | 600,000 | +50.0% | 0.25% | +293.7% |
| Q3 2018 | $2,420,000 | +14.2% | 400,000 | 0.0% | 0.06% | +40.0% |
| Q2 2018 | $2,120,000 | -8.6% | 400,000 | 0.0% | 0.04% | +55.2% |
| Q1 2018 | $2,320,000 | – | 400,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |